Literature DB >> 29122170

Reply.

Whitney W Stevens1, Lydia Suh2, Anju T Peters3, Robert P Schleimer3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29122170      PMCID： PMC6905461          DOI： 10.1016/j.jaip.2017.08.018

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  12 in total

1.  Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.

Authors:  Grazyna Bochenek; Joanna Kuschill-Dziurda; Krystyna Szafraniec; Hanna Plutecka; Andrzej Szczeklik; Ewa Nizankowska-Mogilnicka
Journal:  J Allergy Clin Immunol       Date:  2013-08-27       Impact factor: 10.793

2.  Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.

Authors:  Whitney W Stevens; Christopher J Ocampo; Sergejs Berdnikovs; Masafumi Sakashita; Mahboobeh Mahdavinia; Lydia Suh; Tetsuji Takabayashi; James E Norton; Kathryn E Hulse; David B Conley; Rakesh K Chandra; Bruce K Tan; Anju T Peters; Leslie C Grammer; Atsushi Kato; Kathleen E Harris; Roderick G Carter; Shigeharu Fujieda; Robert C Kern; Robert P Schleimer
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

3.  Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil.

Authors:  Katsuhisa Ikeda; Akihito Shiozawa; Noritsugu Ono; Takeshi Kusunoki; Mikio Hirotsu; Hirotomo Homma; Tatsuya Saitoh; Junko Murata
Journal:  Laryngoscope       Date:  2013-05-13       Impact factor: 3.325

4.  Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity.

Authors:  Mahboobeh Mahdavinia; Roderick G Carter; Christopher J Ocampo; Whitney Stevens; Atsushi Kato; Bruce K Tan; Robert C Kern; David B Conley; Rakesh Chandra; Kathryn E Hulse; Lydia A Suh; James E Norton; Anju T Peters; Leslie C Grammer; Lawrence B Schwartz; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2014-03-15       Impact factor: 10.793

5.  Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease.

Authors:  Grazyna Bochenek; Krystyna Szafraniec; Joanna Kuschill-Dziurda; Ewa Nizankowska-Mogilnicka
Journal:  Respir Med       Date:  2015-03-10       Impact factor: 3.415

6.  Eosinophilic asthma with nasal polyposis march: Is aspirin-exacerbated respiratory disease the last station?

Authors:  İnsu Yılmaz; Murat Türk; Sakine Nazik Bahçecioğlu
Journal:  J Allergy Clin Immunol Pract       Date:  2017 Nov - Dec

7.  Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.

Authors:  Whitney W Stevens; Anju T Peters; Annemarie G Hirsch; Cara M Nordberg; Brian S Schwartz; Dione G Mercer; Mahboobeh Mahdavinia; Leslie C Grammer; Kathryn E Hulse; Robert C Kern; Pedro Avila; Robert P Schleimer
Journal:  J Allergy Clin Immunol Pract       Date:  2017-03-09

8.  Two inflammatory phenotypes of nasal polyps and comorbid asthma.

Authors:  Dawei Wu; Lun Li; Min Zhang; Jianting Wang; Yongxiang Wei
Journal:  Ann Allergy Asthma Immunol       Date:  2017-01-23       Impact factor: 6.347

Review 9.  Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis.

Authors:  Robert P Schleimer
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

10.  Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study.

Authors:  T Tokunaga; M Sakashita; T Haruna; D Asaka; S Takeno; H Ikeda; T Nakayama; N Seki; S Ito; J Murata; Y Sakuma; N Yoshida; T Terada; I Morikura; H Sakaida; K Kondo; K Teraguchi; M Okano; N Otori; M Yoshikawa; K Hirakawa; S Haruna; T Himi; K Ikeda; J Ishitoya; Y Iino; R Kawata; H Kawauchi; M Kobayashi; T Yamasoba; T Miwa; M Urashima; M Tamari; E Noguchi; T Ninomiya; Y Imoto; T Morikawa; K Tomita; T Takabayashi; S Fujieda
Journal:  Allergy       Date:  2015-05-26       Impact factor: 13.146
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.